Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

CRH Medical Corporation T.CRH

Sector: Healthcare | Sub-Sector: Medical Instruments & Supplies

CRH Medical Corp provides physicians with products for the treatment of gastrointestinal diseases. Its product is a single use, disposable, hemorrhoid technology used in treating hemorrhoid grades I - IV.
Price: $3.57 | Change: $-0.06 | %Change: -1.65%
Volume: 157,327 | Day High/Low: 3.66/3.55 | 52 Week High/Low: 4.37/0.65
View modes: 
0 stars

RE:RE:RE:RE:CRH vs Nobilis

all true. The company is not well covered by the street. Hopefully more initiating reports by brokers to get the word out.  rate and reply
0 stars

RE:RE:RE:CRH vs Nobilis

Often I hear analysts comparing CRH with other canadian healthcare stocks that have been booming, like NHC PHM CXV, that they are all growth by acquisitions stories. Well CRH in my view is more
0 stars

RE:RE:Insider Buys

Given the size of insider buy's it would appear the stock was being held up Friday by the owners. Less than 29000 traded otherwise. I own it and I guess we just sit in neutral for now.  rate and reply
1 star

RE:Insider Buys

May 7/15 May 5/15 Johnson, David Direct Ownership Common Shares 10 - Acquisition in the public market 11,450 $2.90 USD May more
0 stars

RE:RE:CRH vs Nobilis

own both and love both . that being said the sector seems to be treading water , at best . like you say patience is the word . then again a little profit taking is never a bad thing .  rate and reply
0 stars

RE:CRH vs Nobilis

this is a great question. I struggle with this as well. Seems like NHC trades better than us (good volume, etc.). My view is that CRH has some catching up to do, so right now i'd be long more CRH more
0 stars

CRH vs Nobilis

Pretty quiet here.  Lots of chatter/excitement on NHC.  Both companies have a similar growth by acquisition strategy.  Last financing on CRH was last March and they have not made another purchase more
5 stars

Insider Buys

2 directors buying in the open market. Always a good sign!  rate and reply
0 stars


Three cheers for Jason Donville:)  rate and reply
0 stars


Second stock in the clip. GLTA Vancouver based CRH Medical has emerged as one of the more exciting companies in the allied medical services more
0 stars

Bruce Campbell Interview

inThe Life Sciences Report One company that we're pretty excited about going forward is CRH Medical Corp. (OTCQX:CRMMF) [CRH:TSX]. Again, this is an acquisition story. The company has its own more
3 stars

top pick jason donville marketcall on bnn

top pick number 2. here goes all the chasing. lol. let it subside from the call. cheers, dave.  rate and reply
1 star

Donville top pick

1 year $5+  rate and reply
0 stars

RE:Bloom Burton Conference

Anyone lucky enough to be at the conference, kindly share latest info..Thanks!!!  rate and reply
5 stars

Beacon Securities Commentary (6.00 TP)

CRH Medical Corporation (CRH-T) Record Quarterly Results   CRH reported record quarterly results with $9.6 million in revenue and $5.1 million in EBITDAS (53%) versus $2.0/$0.7 million ( more
0 stars

Bloom Burton Conference

CRH presented at 10:30 this morning. GLTA  rate and reply
0 stars

Q1 Seasonality

HOUSTON, TX--(Marketwired - April 09, 2015) - Nobilis Health Corp. (TSX: NHC) announces, on a consolidated basis, that its estimated revenue for the three months ending March 31, 2015 is between $ more
1 star

Analyst Comment

Last stock in the clip; a very fast comment. GLTA 2015-05-01 BUY on WEAKNESS Bruce Campbell (1) (Market Call Minute.) A growth by more
0 stars

the state of biotech in Canada  rate and reply
0 stars

RE:RE:Clarus Ups Target to 5.50

1.15-1.25 fx. fairly immaterial imo. If we go to parity, another story.  At 3.50, we're cheap regardless. Too cheap. Especially when you benchmark us against CXV, PHM, CXR, GUD, etc.  rate and reply